Patrick Griffin
Keine laufenden Positionen mehr
Profil
Patrick H.
Griffin worked as an Associate Vice President-Clinical Development at Sanofi, Inc. from 2009 to 2012.
He then worked as the Chief Medical Officer & Senior VP-Development at ImmusanT, Inc. in 2012-2013.
From 2013 to 2018, he served as the Chief Medical Officer & Executive Vice President at Synergy Pharmaceuticals LLC.
Currently, he is the Chief Medical Officer at 9 Meters Biopharma, Inc. since 2019.
Dr. Griffin holds a doctorate degree from The Trustees of Columbia University in The City of New York.
Ehemalige bekannte Positionen von Patrick Griffin
| Unternehmen | Position | Ende |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.07.2023 |
| SYNERGY PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2013 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Patrick Griffin
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
